CSTL — Castle Biosciences Inc · rev $187.2M

Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.

Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.

Use this CSTL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CSTL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CSTL SEC filings page. Lician reads the product cache first so this HTML stays unique to Castle Biosciences Inc even when a live quote feed is slow.

Castle Biosciences Inc latest statements (FY2025)

Latest cached year on this hub. Full CSTL income, balance, and cash tables.

  • Revenue$344.2M
  • Net Income-$24.2M
  • Total Assets$578.6M
  • Total Debt$0
  • Free Cash Flow$28.3M

CSTL recent filings